Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system
Related Posts
Ahmed M, Shafiq A, Javaid H, Singh P, Shahbaz H, Maniya MT, Jain H, Shakir N, Cheema HA, Ahmad A, Rehman WU, Yeap G, Nashwan[...]
Matilainen J, Berg V, Vaittinen M, Impola U, Mustonen AM, Männistö V, Malinen M, Luukkonen V, Rosso N, Turunen T, Käkelä P, Palmisano S, Arasu[...]
Ells Z, Grogan TR, Czernin J, Dahlbom M, Calais J. Dosimetry of [177Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and[...]